As an activator of pro-uPA, uPAR binds to pro-uPA as well as the active uPA fragment and subsequently may enhance plasminogen conversion both locally at the invasive tumor front with uPAR and systemically with suPAR binding [35, 36]. Here, PLG is linked to neoplasm.